Jilin Aodong Pharmaceutical Group Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -17.43% vs -26.76% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 67.49% vs 289.22% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "514.10",
          "val2": "622.60",
          "chgp": "-17.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "20.70",
          "val2": "50.20",
          "chgp": "-58.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "15.30",
          "val2": "6.10",
          "chgp": "150.82%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-49.20",
          "val2": "7.30",
          "chgp": "-773.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "865.10",
          "val2": "516.50",
          "chgp": "67.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "40.40%",
          "val2": "-8.00%",
          "chgp": "4.84%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -10.78% vs -23.69% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 55.43% vs 5.19% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,316.70",
          "val2": "2,596.50",
          "chgp": "-10.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "58.40",
          "val2": "99.50",
          "chgp": "-41.31%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "52.90",
          "val2": "94.50",
          "chgp": "-44.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-3.80",
          "val2": "-187.00",
          "chgp": "97.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,361.30",
          "val2": "1,519.20",
          "chgp": "55.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-69.00%",
          "val2": "-53.50%",
          "chgp": "-1.55%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

514.10

622.60

-17.43%

Operating Profit (PBDIT) excl Other Income

20.70

50.20

-58.76%

Interest

15.30

6.10

150.82%

Exceptional Items

-49.20

7.30

-773.97%

Consolidate Net Profit

865.10

516.50

67.49%

Operating Profit Margin (Excl OI)

40.40%

-8.00%

4.84%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is -17.43% vs -26.76% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 67.49% vs 289.22% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

2,316.70

2,596.50

-10.78%

Operating Profit (PBDIT) excl Other Income

58.40

99.50

-41.31%

Interest

52.90

94.50

-44.02%

Exceptional Items

-3.80

-187.00

97.97%

Consolidate Net Profit

2,361.30

1,519.20

55.43%

Operating Profit Margin (Excl OI)

-69.00%

-53.50%

-1.55%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -10.78% vs -23.69% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 55.43% vs 5.19% in Dec 2024

All Annual Results